FIRST TRUST ADVISORS LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,253,993
+11.8%
36,325
+6.3%
0.00%
+33.3%
Q2 2023$2,910,510
-27.6%
34,185
-29.6%
0.00%
-40.0%
Q1 2023$4,019,498
-10.2%
48,574
-14.6%
0.01%0.0%
Q4 2022$4,475,971
+712.3%
56,910
+664.7%
0.01%
+400.0%
Q3 2022$551,000
-7.9%
7,442
-18.9%
0.00%0.0%
Q2 2022$598,000
-18.2%
9,180
-20.6%
0.00%0.0%
Q1 2022$731,000
+59.3%
11,555
+33.6%
0.00%
Q4 2021$459,000
-92.9%
8,652
-91.0%
0.00%
-100.0%
Q2 2021$6,429,000
-4.7%
96,475
+58.8%
0.01%
-12.5%
Q1 2021$6,745,000
+2.7%
60,759
+9.8%
0.01%
-11.1%
Q4 2020$6,570,000
+230.8%
55,326
+149.5%
0.01%
+200.0%
Q2 2020$1,986,000
-44.8%
22,175
-29.1%
0.00%
-50.0%
Q4 2019$3,595,000
-26.0%
31,284
-18.8%
0.01%
-33.3%
Q3 2019$4,861,000
+49.0%
38,539
+3.4%
0.01%
+50.0%
Q1 2019$3,262,000
-17.1%
37,285
-5.2%
0.01%
-33.3%
Q4 2018$3,936,000
-31.7%
39,345
-21.8%
0.01%
-18.2%
Q3 2018$5,762,000
+25.0%
50,288
-2.1%
0.01%
+10.0%
Q2 2018$4,608,000
+259.7%
51,388
+66.0%
0.01%
+233.3%
Q2 2015$1,281,000
+139.0%
30,963
+116.3%
0.00%
+50.0%
Q4 2014$536,000
-2.5%
14,318
-9.1%
0.00%0.0%
Q3 2014$550,000
-4.0%
15,749
-3.0%
0.00%0.0%
Q2 2014$573,000
+5.3%
16,235
-2.7%
0.00%0.0%
Q1 2014$544,000
-4.4%
16,693
+23.7%
0.00%
-33.3%
Q4 2013$569,000
+127.6%
13,496
+115.5%
0.00%
+200.0%
Q3 2013$250,000
+17.4%
6,264
+21.7%
0.00%0.0%
Q2 2013$213,0005,1490.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders